Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hambrecht & Quist (H&Q) was a premier investment bank and venture capital firm that played a foundational role in the growth of the biotechnology and life sciences industries. Founded in 1968, the firm became renowned for identifying and financing high-growth technology and healthcare companies, famously underwriting the initial public offerings of industry pioneers such as Genentech and Amgen. H&Q's specialized focus on emerging growth sectors helped establish the financial infrastructure necessary for the modern biotech era. The firm was acquired by Chase Manhattan Bank in 1999, which subsequently merged with J.P. Morgan & Co. to form JPMorgan Chase. Today, its legacy continues through the annual J.P. Morgan Healthcare Conference, which originated as the H&Q Healthcare Conference.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hambrecht.